Cancer immunotherapy - Globe Thesis

Keyword [Cancer immunotherapy] Result: 181 - 199 \| Page: 10 of 10
181.	The Prognostic Value Of Peripheral Blood Inflammatory Markers In Patients With Advanced Non-small Cell Lung Cancer Treated With Anti-PD-1 Immunotherapy
182.	The Molecular Mechanism Study Of Anti-tumor Effect Of Peptide Vaccine
183.	Cascade Chemo-photodynamic Therapy By A ROS-responsive Nanocarrier To Potentiate Checkpoint Blockade Immunotherapy For Cancer Treatment
184.	Application Of Novel Self-assembled Microspheres In Cancer Immunotherapy
185.	Genetically Engineered Cytomembrane Vesicles For Enhancing Cancer Immunotherapy
186.	The Recombinant Trichosanthin-Antigen Peptide Vaccine For Cancer Immunotherapy
187.	Recombinant Endoglin-scFv/IP10 Fusion Protein Potently Boosts The Anti-tumor Efficacy Of Adoptively Transferred Specific CD8~+CD28~+ Cytotoxic T Lymphocytes In Mice
188.	Expression And Clinical Significance Of CCL5 And CD8 In Colorectal Cancer
189.	Potential Predictive Value Of TP53 And ARID1A Co-mutation To Immune Checkpoint Inhibitors Therapy In Gastric Cancer
190.	Expression And Clinical Significance Of PTPN2 And PD-L1 In Gastric Cancer
191.	Efficacy And Prognostic Factors Analysis Of Camrelizumab Combined With Chemotherapy For Advanced Esophageal Squamous Cell Carcinoma
192.	DIM Enhances Gastric Cancer Immunotherapy Through Up-regulating KLF4 Expression And Inhibiting PD-L1
193.	Effects Of ?-catenin/TCF Inhibition On Tumor Immune Microenvironment In Colorectal Cancer
194.	Synthesis Of NK Cell-mimetic Multifunctional Nanohybrids And Application In Breast Cancer Immunotherapy
195.	Study Of Biocompatible Nano Drug Carriers For Triple Negative Breast Cancer Immunotherapy
196.	Basic Study On The Therapeutic Function Of Tri-specific Antibodies Targeting CD3-TROP2-PDL1 On Triple-negative Breast Cancer
197.	Complete Rejection Of Established Triple Negative Breast Cancer By Local Immunochemotherapy Through Activation Of Anti-tumor Immunity
198.	Prediction Of Prognosis And Immunotherapy Prognosis Of Breast Cancer By Immune Related Gene Model
199.	Design,Synthesis And Evaluation Of Novel Small Molecule PD-L1 Inhibitors
<<First <Prev Next> Last>> Jump to